
Accuracy should not be optional
Carbon-fiber. 360 degree mounting. Phantom.
The definition of versatility.
Meet SUSy
inomed Stereotactic Ultralight System
Modern functional neurosurgery demands the highest level of precision, with procedures now being so minimally invasive that accuracy is paramount. The inomed Stereotactic Ultralight System (SUSy) has been meticulously developed in collaboration with neurosurgeons to achieve sub-millimetre accuracy, ensuring optimal patient outcomes.
​
Designed to support a broad range of both routine and complex neurosurgical procedures, SUSy is a versatile system that facilitates stereotactic biopsy, deep brain stimulation (DBS) implantation with microelectrode recording, and minimally invasive electrode implantation for epilepsy diagnostics. With sub-millimetre targeting accuracy, SUSy enables surgeons to reach even the smallest and most deeply located brain structures with confidence.
SUSy’s cutting-edge design supports multiple mounting options on titanium or ceramic headrings, allowing configurations from left-right and anterior-posterior positions, all while maintaining a sterile barrier. The system also features a target point simulator, enabling surgeons to confirm the planned trajectory via surgical navigation software prior to surgical intervention, ensuring accuracy before electrode implantation or biopsy procedures.
Weighing in at less than 2kg, SUSy is constructed from carbon-fibre reinforced PEEK, a material originally engineered for space exploration. This lightweight yet durable design eliminates interference on intraoperative CT scans, allowing surgeons to verify accurate electrode placement in real time—a significant advantage over traditional systems that often produce imaging artifacts.

While robotic surgical systems often prioritize workflow efficiency, SUSy redefines accuracy in stereotactic neurosurgery. Its lightweight, interference-free, and highly adaptable design is pushing the boundaries of what is possible in minimally invasive neurosurgery, introducing a new gold standard.



inomed was founded in 1991 by the current Managing Director Rudi Mattmüller and Plant Manager Dieter Mussler, and with the development of stimulation probes for identifying and protecting facial nerves in addition to developing instruments for minimally invasive pain treatment.
The company has since grown into a company with a staff of more than 160 employees, is now doing business around the world and has branch offices in the UK, Poland, France, the U.S and Italy. With its continual growth, inomed has been able to secure employment for people living in the region and is continually expanding its workforce.
"Stereotactic systems afford a degree of submillimetre accuracy that can't yet be afforded by robotic systems. The versatility of mounting options partnered with carbon fiber material presents a formidable stereotactic solution that will favour positive patient outcomes."
Ryan Hamer
Managing Director
inomed's R&D team, working closely with research partners, is engaged in the development of new products and technologies for the healthcare professional. The inomed R&D team has created a portfolio that includes products in the fields of intraoperative neuromonitoring, functional neurosurgery, pain treatment and neurological diagnostics.